Found 7 matching trials
Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia PHASE2 RATIONALE: Monoclonal antibodies such as gemtuzumab ozogamicin can locate c...
Show More Location
Ziekenhuis Netwerk Antwerpen Middelheim
Learn More & Join Trial
Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia PHASE2 Acute myeloid leukemia (AML) is among the most common hematologic malignanc...
Show More Location
University of Nebraska Medical Center
Learn More & Join Trial
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations PHASE3 This phase III trial compares standard chemotherapy to therapy with liposom...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML PHASE2 This phase II clinical trial evaluates the efficacy and tolerability of the...
Show More Location
Universitätsklinikum Essen
Learn More & Join Trial
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) PHASE2 This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC) PHASE1 This phase I/II clinical trial evaluates the safety and efficacy of the com...
Show More Location
LMU Klinikum, Campus Großhadern
Learn More & Join Trial
Atovaquone (Mepron®) Combined With Conventional Chemotherapy for de Novo Acute Myeloid Leukemia (AML) EARLY_PHASE1 This study will test daily dosing of atovaquone at established pneumocystis...
Show More Location
Johns Hopkins Medicine
Learn More & Join Trial